Chemico-pharmaceutical preparations, namely human pharmaceuticals and drugs for the treatment of immuno-oncology diseases and cancer therapies; injectable pharmaceutical preparations, namely human treatment vaccines and therapeutic vaccines for the treatment of immuno-oncology diseases and cancer therapies; injectable solutions for medical purposes, namely human treatment vaccines and therapeutic vaccines used for the treatment of immuno-oncology diseases and cancer therapies; troche, namely human pharmaceutical preparations and supplements for the treatment of immuno-oncology diseases and cancer therapies; medicines based on biologically active substances, namely biopharmaceuticals for the treatment of immune-oncology diseases and cancer therapies; blood substitutes for medical or veterinary use; medicines for human purposes, namely used for the treatment of immuno-oncology diseases and cancer therapies; drugs for medical purposes, namely used for the treatment of immuno-oncology diseases and cancer therapies; biological preparations for medical purposes, namely biological preparations made from human blood cells used for the treatment of immuno-oncology diseases and cancer therapies; stem cells for medical purposes; biochemical drug, namely used for the treatment of immuno-oncology diseases and cancer therapies.
REGISTERED
on 25 Oct 2024
ADLAINORTYE
HANGZHOU ADLAI NORTYE BIOPHARMA CO. LTD.
2168434 · 20 Oct 2021
005
Class 005
Pharmaceutical Products
Chemico-pharmaceutical preparations, namely human pharmaceuticals and drugs for the treatment of immuno-oncology diseases and cancer therapies; injectable pharmaceutical preparations, namely human treatment vaccines and therapeutic vaccines for the treatment of immuno-oncology diseases and cancer therapies; injectable solutions for medical purposes, namely human treatment vaccines and therapeutic vaccines used for the treatment of immuno-oncology diseases and cancer therapies; troche, namely human pharmaceutical preparations and supplements for the treatment of immuno-oncology diseases and cancer therapies; medicines based on biologically active substances, namely biopharmaceuticals for the treatment of immune-oncology diseases and cancer therapies; blood substitutes for medical or veterinary use; medicines for human purposes, namely used for the treatment of immuno-oncology diseases and cancer therapies; drugs for medical purposes, namely used for the treatment of immuno-oncology diseases and cancer therapies; biological preparations for medical purposes, namely biological preparations made from human blood cells used for the treatment of immuno-oncology diseases and cancer therapies; stem cells for medical purposes; biochemical drug, namely used for the treatment of immuno-oncology diseases and cancer therapies.
Chemico-pharmaceutical preparations, namely human pharmaceuticals and ...